ISIA shall establish, promote and assure compliance with uncompromised standards of excellence and ethics in the business practices of the global animal serum and animal derived products supply industry.
SAFETY AND SAFE USE
Our primary focus will be on safety and safe use of serum and animal derived products through proper origin traceability, and truth in labeling, and appropriate standardization and oversight.
We will also work to educate stakeholders on the scientific foundation of the safe use of serum and animal derived products.
ISIA is working to harmonize technical standards, testing methods, and import/export for the industry.
ISIA is working to proactively educate those involved with our products about our industry, and our Association.
ISIA is working to broaden its membership to be able to better represent the industry.
ISIA is working to interpret regulations, participate in the development of new regulations affecting our industry, and strengthen our position as resource and liason with global regulatory agencies.
ISIA is working to continually improve, promote, and manage the ISIA Traceability Program. Additionally, ISIA is working to strengthen the Traceability Program in the future by researching the applicability of quantitative methods and new technologies in the Serum industry.
Below see a schematic of the ISIA global contacts.
|Randy Fitzgerald||Vice-Chairman||Proliant Biologicals|
|Stephen Judd||Director||Axenia BioLogix|
|Rick Mulford||Director||Vacca Biologics|
|Nicole Green||Director||Central Biomedia|
||River City Biologicals
|Bob Curry||Director||GE Healthcare|
|Jock Elliott||Secretary*||Moregate Biotech|